|
시장보고서
상품코드
1997063
프리필드 시린지 시장 규모 및 예측(2021-2034년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 범위 - 유형별, 재질별, 제품 유형별, 용도별, 유통 채널별Prefilled Syringes Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Material, Product Type, Application, Distribution Channel |
||||||
프리필드 시린지 시장은 2025년 88억 3,000만 달러에서 2034년까지 203억 2,000만 달러에 이를 것으로 예측됩니다. 이 시장은 2026-2034년 CAGR 9.9%를 기록할 것으로 추정됩니다. 시장 성장을 가속하는 주요 요인으로서는 만성질환 유병률 상승에 가세해 생물학적 제제 및 바이오시밀러 진보, 자기 투여나 재택치료 보급 확대가, 프리필드 시린지 채택을 지지하고 있습니다. 또한 예방 접종 프로그램 확대나 공중위생 시책도, 예측 기간 중에 시장을 밀어 올리는 요인이 되겠지요.그러나, 높은 제조·개발비나 엄격한 규제 요건, 승인 지연등이, 시장 성장 억제요인되고 있습니다.
바이오의약품 및 바이오시밀러의 발전으로 복잡한 단백질 및 단일 클론 항체를 위한 안정적이고 사용하기 쉬운 투여 시스템이 개발되고 있습니다. 프리필드시린지는 분해를 최소화하고 무균성을 확보하여 종양학, 자가면역질환 등의 치료 영역에서 정확한 투여를 가능하게 합니다. WHO에 따르면, 2022년에는 암(생물학적 제제 관련) 등 비감염성 질환이 전 세계 사망 원인의 74%를 차지할 것으로 예상되며, 생물학적 제제는 표적치료에 사용되고 있습니다. 미국 FDA에 따르면, 2023년에는 37개의 새로운 생물학적 제제가 승인될 것으로 예상되며, 그 중 상당수는 주사제 형태를 필요로 합니다. 유럽의약품청(EMA)에 따르면, 2024년에는 바이오시밀러 승인 건수가 증가하여 15종의 새로운 바이오시밀러가 승인되었습니다. 이들은 비용 효율적인 접근을 위해 종종 미리 채워진 주사기로 제공되어 비용 효율적인 접근을 가능하게 합니다. 미국 질병예방통제센터(CDC)에 따르면, 2022년 미국 내 암 유병률은 1,810만 명의 생존자에게 영향을 미칠 것으로 예상되며, 이는 바이오로직스 수요를 견인하고 있습니다. 인도에서는 인도 의학연구위원회(ICMR)에 따르면 2022년 암 발병 건수가 146만 건에 달할 것으로 예상되며, 주사용 생물학적 제제에 대한 의존도가 높아지고 있습니다. 신제품 개발 동향이 이를 여실히 보여주고 있습니다. 미국 식품의약국(FDA)에 따르면, 2024년 2월 골전이 치료용 데노수맙 바이오시밀러(삼성바이오에피스)가 프리필드시린지 제제로 승인됐습니다. 유럽의약품청(EMA)에 따르면, 2023년 자가면역질환 치료용 우스테키누맙 바이오시밀러(Pyzchiva)가 프리필드시린지 제제로 승인됐습니다. 이 밖에도 희귀질환 치료제인 에프가르티기모드의 근위축증 치료제 프리필드시린지가 2024년 FDA의 승인을 받았으며, 2022년 EMA는 바이오시밀러 프리필드시린지 형태의 바이오시밀러를 권장하는 가이드라인을 승인해 경제성을 확보했습니다.의 승인을 받은 것을 들 수 있습니다.
경쟁사 분석에서는 제품 포트폴리오(제품 만족도, 제품 기능, 가용성), 최근 시장 동향(인수합병, 신제품 출시 및 개선, 투자 및 자금 조달, 수상, 계약, 제휴 및 파트너십, 평가, 사업 확장), 지리적 분포에 따라 프리필드 주사기 시장을 평가 및 분류하여 이를 통해 의사결정을 지원하고 경쟁 구도를 더 잘 이해할 수 있도록 돕습니다. 이 보고서는 세계 프리필드시린지 시장의 주요 업체들의 최근 주요 동향과 혁신에 대해 심층적으로 분석했습니다. 주요 시장 기업으로는 게레스하이머 AG, 쇼트 그룹, 니프로 주식회사, BD, 박스터 인터내셔널, 텔모, 입소메드, 웨가오 그룹, 발룬, 델타메드 등이 있습니다.
유형별로 보면, 프리필드시린지 시장은 일회용 프리필드시린지와 재사용 가능한 프리필드시린지로 나뉩니다. 2025년에는 일회용 프리필드시린지 부문이 시장 점유율의 대부분을 차지했습니다. 일회용 프리필드시린지는 편리성, 오염 위험 감소, 규제 권장 사항, 저렴한 비용, 안전성 향상, 백신 접종 프로그램 확대 등으로 인해 선호되고 있습니다.
재료별로 보면, 프리필드시린지 시장에는 유리 프리필드시린지와 플라스틱 프리필드시린지가 포함됩니다. 2025년에는 유리 프리필드시린지 부문이 시장 점유율의 대부분을 차지했습니다. 유리 프리필드시린지는 약물의 안정성, 우수한 차단성, 화학적 호환성, 규제 당국의 승인 및 바이오 의약품에 대한 광범위한 사용을 보장합니다.
제품 유형별로 보면, 프리필드시린지 시장은 싱글 챔버형과 멀티 챔버형으로 나뉩니다. 2025년에는 단일 챔버 유형 부문이 프리필드시린지 시장에서 더 큰 점유율을 차지했습니다. 단일 챔버형 프리필드시린지는 단순한 디자인, 사용 편의성, 낮은 제조 복잡성, 비용 절감, 그리고 전 세계 대량 투여 요법의 보급으로 성장하고 있습니다.
용도별로 보면, 프리필드시린지 시장은 암, 당뇨병, 심혈관 질환, 자가면역질환, 감염질환, 기타로 분류됩니다. 2025년에는 "기타" 용도가 시장의 대부분을 차지했습니다. '기타'의 용도는 신경질환, 알레르기, 피부질환, 내분비질환, 호흡기질환에 사용되어 주사 요법의 채택이 증가하고 있습니다.
유통 채널별로 보면, 프리필드시린지 시장은 병원 약국, 소매 약국, 온라인 채널로 분류됩니다. 2025년에는 병원 약국 부문이 시장의 대부분을 차지했습니다. 병원 약국 채널은 환자 수, 집중 치료에서의 사용, 의사의 선호도, 엄격한 보관 관리 및 의료기관의 구매력으로 인해 성장하고 있습니다.
프리필드시린지 시장에서 사업을 전개하는 기업들은 다양한 유기적 및 무기적 전략을 채택하고 있습니다. 유기적 전략에는 주로 제품 출시와 승인 등이 포함됩니다. 시장에서 볼 수 있는 무기적 성장 전략으로는 인수, 제휴, 파트너십을 들 수 있습니다. 이러한 성장 전략을 통해 시장 참여자들은 사업을 확장하고, 지리적 입지를 강화하며, 전체 시장 성장에 기여할 수 있습니다. 또한, 인수 및 파트너십을 통해 고객 기반을 강화하고 제품 포트폴리오를 확장하는 데에도 기여했습니다. 프리필드시린지 시장의 주요 업체들의 주요 동향은 다음과 같습니다.
2025년 10월, 벡톤 디킨슨 앤 컴퍼니(BD)는 고점도 생물학적 제제를 위한 자가주사 솔루션을 강화하기 위해 주사 시스템의 선도적인 공급업체인 입소메드(Ypsomed)와의 전략적 제휴를 발표했습니다. BD와 입소메드는 공동 이니셔티브를 통해 BD의 'Neopak XtraFlow'유리 프리필드 주사기와 입소메드의 'YpsoMate 2.25'자동 주사기 플랫폼과의 통합에 대한 사전 평가 및 최적화를 수행했습니다. 이번 제휴를 통해 15cP 이상의 점도를 가진 생물학적 제제를 자동 주사기 형태로 투여할 수 있게 되어 기존 문제를 해결할 수 있게 되었습니다.
2024년 3월, B. Braun SE는 Orlando Health와 협력하여 환자와 의료진의 의료 접근성을 향상시키는 혁신적인 솔루션을 공동 개발했습니다. 이번 제휴는 약국 및 수액 치료 분야의 과제 해결을 우선순위에 두고, 의료진의 초기 피드백을 수집하여 니즈를 파악하고 최적의 솔루션을 개발하는 데 중점을 두고 있습니다.
목차
제1장 주요 요약
제2장 프리필드 시린지 시장 구도
제3장 경쟁 구도
제4장 프리필드 시린지 시장 - 주요 시장 역학
제5장 프리필드 시린지 시장 - 세계 시장 분석
제6장 프리필드 시린지 시장 매출 분석 - 유형별
제7장 프리필드 시린지 시장 매출 분석 - 소재별
제8장 프리필드 시린지 시장 매출 분석 - 디자인
제9장 프리필드 시린지 시장 매출 분석 - 용도별
제10장 프리필드 시린지 시장 매출 분석 - 유통 채널
제11장 프리필드 시린지 시장 - 지역 분석
제12장 프리필드 시린지 시장 상황
제13장 프리필드 시린지 시장 - 주요 기업 개요
제14장 부록
LSH 26.04.20The prefilled syringes market is projected to reach US$20.32 Billion by 2034 from US$8.83 Billion in 2025. The market is estimated to register a CAGR of 9.9% during 2026-2034. Major factors driving the market growth include the rising prevalence of chronic diseases, as well as advancements in biologics and biosimilars, and increasing adoption of self-administration and home healthcare are propelling the adoption of prefilled syringes. Further, expanded vaccination programs and public health initiatives will likely boost the market during the forecast period. However, high manufacturing and development costs and stringent regulatory requirements, and approval delays are among the market deterrents.
Advancements in biologics and biosimilars are leading to the development of stable, user-friendly delivery systems for complex proteins and monoclonal antibodies, with prefilled syringes minimizing degradation, ensuring sterility, and facilitating precise administration in therapeutic areas such as oncology and autoimmune diseases. According to the WHO, in 2022, noncommunicable diseases such as cancer (linked to biologics) caused 74% of global deaths, with biologics used for targeted therapies. According to the U.S. FDA, in 2023, 37 new biologics were approved, many requiring injectable formats. According to the EMA, in 2024, biosimilar approvals rose, with 15 new biosimilars authorized, often in prefilled syringes for cost-effective access. According to the CDC, in the US in 2022, cancer prevalence affected 18.1 million survivors, driving biologic demand. In India, according to the Indian Council of Medical Research, cancer incidence reached 1.46 million cases in 2022, increasing reliance on injectable biologics. New product developments exemplify this: according to the U.S. FDA, in February 2024, denosumab biosimilars (Samsung Bioepis) were approved in prefilled syringes for bone metastases. According to the EMA, in 2023, ustekinumab biosimilars (Pyzchiva) gained approval in prefilled syringes for autoimmune conditions. Other instances include the FDA's 2024 approval of efgartigimod prefilled syringe for myasthenia gravis, a biologic for rare diseases, and EMA's 2022 endorsement of guidelines promoting biosimilar prefilled formats to enhance affordability.
The comparative company analysis evaluates and categorizes the prefilled syringes market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global Prefilled Syringes market. The key market players are Gerresheimer AG, Schott Group, Nipro Medical Corporation, BD, Baxter International Inc., Terumo, YPSOMED, Weigao Group, Barun, and Deltamed.
Based on type, the prefilled syringes market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held a larger prefilled syringes market share in 2025. Disposable prefilled syringes are preferred due to convenience, reduced contamination risk, regulatory preference, lower costs, improved safety, and rising vaccination programs.
By material, the prefilled syringes market includes glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held a larger prefilled syringes market share in 2025. Glass prefilled syringes ensure drug stability, superior barrier properties, chemical compatibility, regulatory acceptance, and widespread biologics usage.
In terms of product type, the prefilled syringes market is divided into single-chamber and multi-chamber. The single-chamber segment held a larger prefilled syringes market share in 2025. Single-chamber prefilled syringes grow because of simpler design, ease of use, lower manufacturing complexity, reduced costs, and high-volume therapies globally.
By application, the prefilled syringes market is divided into cancer, diabetes, cardiovascular disease, autoimmune disease, infectious disease, and others. Other applications made up a large part of the market in 2025. Other applications are expanding by use in neurological disorders, allergies, dermatological conditions, endocrine disorders, and respiratory diseases, increasing injectable therapy adoption.
By distribution channel, the prefilled syringes market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment made up a large part of the market in 2025. Hospital pharmacy channels grow due to high patient inflow, critical care usage, physician preference, controlled storage, and institutional purchasing power.
Companies operating in the Prefilled Syringes market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses, enhance their geographic presence, and contribute to the overall market growth. Furthermore, acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few significant developments by key Prefilled Syringes market players are listed below.
In October 2025, Becton, Dickinson and Company announced a strategic partnership with Ypsomed, a leading provider of injection systems, to enhance self-injection solutions for high-viscosity biologic drugs. Through a joint initiative, BD and Ypsomed have pre-assessed and optimized the integration of the BD Neopak XtraFlow Glass Prefillable Syringe with Ypsomed's YpsoMate 2.25 autoinjector platform. This collaboration addresses existing challenges by enabling the delivery of biologic drugs with viscosities exceeding 15 cP in autoinjector format.
In March 2024, B. Braun SE collaborated with Orlando Health to co-create innovative solutions that enhance access to care for patients and clinicians. This collaboration will prioritize addressing disruptions in the pharmacy and infusion therapy sectors, emphasizing the collection of early clinician feedback to identify needs and develop tailored solutions.
Table Of Contents
1. Executive Summary
- 1.1 Analyst Market Outlook
- 1.2 Market Attractiveness
2. Prefilled Syringe Market Landscape
- 2.1 Overview
- 2.2 Value Chain Analysis
- 2.2.1 Raw Material Suppliers / Components
- 2.2.2 Manufacturers Process / Technology
- 2.2.3 Distribution Landscape
- 2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
- 2.4 Porter's Five Force Analysis
- 2.4.1 Bargaining Power of Suppliers:
- 2.4.2 Threat of New Entrants:
- 2.4.3 Threat of Substitutes:
- 2.4.4 Competitive Rivalry:
- 2.5 PEST Analysis
- 2.6 Impact of Artificial Intelligence (AI)
- 2.6.1 Enhanced Manufacturing Precision and Quality Control:
- 2.6.2 Predictive Maintenance and Reduced Downtime:
- 2.6.3 Accelerated R&D and Design Innovation:
- 2.6.4 Supply Chain Optimization:
- 2.6.5 Personalized Medicine and Smart Syringes:
- 2.6.6 Regulatory Compliance and Documentation:
- 2.7 Product or Technology Roadmap
- 2.7.10-2021: Pandemic-Driven Adoption and Capacity Expansion
- 2.7.21-2022: Multiplexing and Clinical Validation
- 2.7.32-2023: Automation, High-Throughput, and Laboratory Integration
- 2.7.43-2024: Point-of-Care, Decentralization, and Digital Integration
- 2.7.54-2025: AI-Driven Optimization and Next-Generation Prefilled Syringe
- 2.8 Sustainability and ESG Trends
- 2.8.1 Environmental Trends
- 2.8.2 Social Trends
- 2.8.3 Governance Trends
- 2.9 Regulatory Framework
3. Competitive Landscape
- 3.1 Company Benchmarking by Key Players
- 3.2 Market Concentration
4. Prefilled Syringe Market - Key Industry Dynamics
- 4.1 Market Drivers
- 4.1.1 Rising Prevalence of Chronic Diseases
- 4.1.2 Advancements in Biologics and Biosimilars
- 4.1.3 Increasing Adoption of Self-Administration and Home Healthcare
- 4.2 Market Restraints
- 4.2.1 High Manufacturing and Development Costs
- 4.2.2 Stringent Regulatory Requirements and Approval Delays
- 4.2.3 Risk of Product Recalls and Safety Concerns
- 4.3 Market Opportunities
- 4.3.1 Chronic Disease Prevalence and Patient?Centric Injection Needs
- 4.3.2 Expanded Vaccination Programs and Public Health Initiatives
- 4.3.3 Innovation in Biologics and Regulatory Support for Safety Features
- 4.4 Future Trends
- 4.4.1 Surging Preference for Self-Administration and Home-Based Healthcare
- 4.4.2 Rapid Integration of Biologics and Biosimilars
- 4.4.3 Focus on Sustainability and Eco-Friendly Manufacturing
- 4.5 Impact of Drivers and Restraints
5. Prefilled Syringe Market - Global Market Analysis
- 5.1 Prefilled Syringe Market Revenue (US$ Million), 2021-2034
- 5.2 Prefilled Syringe Market Forecast and Analysis
6. Prefilled Syringe Market Revenue Analysis -Type
- 6.1 Prefilled Syringe Market Forecasts and Analysis by Type
- 6.1.1 Disposable Prefilled Syringes
- 6.1.1.1 Overview
- 6.1.1.2 Disposable Prefilled Syringes: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 6.1.2 Reusable Prefilled Syringes
- 6.1.2.1 Overview
- 6.1.2.2 SReusable Prefilled Syringes: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 6.1.1 Disposable Prefilled Syringes
7. Prefilled Syringe Market Revenue Analysis -Material
- 7.1 Prefilled Syringe Market Forecasts and Analysis by Material
- 7.1.1 Glass Prefilled Syringes
- 7.1.1.1 Overview
- 7.1.1.2 Glass Prefilled Syringes: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 7.1.2 Plastic Prefilled Syringes
- 7.1.2.1 Overview
- 7.1.2.2 Plastic Prefilled Syringes: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 7.1.1 Glass Prefilled Syringes
8. Prefilled Syringe Market Revenue Analysis -Design
- 8.1 Prefilled Syringe Market Forecasts and Analysis by Design
- 8.1.1 Single chamber
- 8.1.1.1 Overview
- 8.1.1.2 Single chamber: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 8.1.2 Multi-chamber
- 8.1.2.1 Overview
- 8.1.2.2 Multi-chamber: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 8.1.1 Single chamber
9. Prefilled Syringe Market Revenue Analysis -Application
- 9.1 Prefilled Syringe Market Forecasts and Analysis by Application
- 9.1.1 Cancer
- 9.1.1.1 Overview
- 9.1.1.2 Cancer: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 9.1.2 Diabetes
- 9.1.2.1 Overview
- 9.1.2.2 Diabetes: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 9.1.3 Autoimmune Diseases
- 9.1.3.1 Overview
- 9.1.3.2 Autoimmune Diseases: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 9.1.4 Infectious Diseases
- 9.1.4.1 Overview
- 9.1.4.2 Infectious Diseases: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 9.1.5 Other Applications
- 9.1.5.1 Overview
- 9.1.5.2 Other Applications: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 9.1.1 Cancer
10. Prefilled Syringe Market Revenue Analysis -Distribution Channel
- 10.1 Prefilled Syringe Market Forecasts and Analysis by Distribution Channel
- 10.1.1 Hospital Pharmacy
- 10.1.1.1 Overview
- 10.1.1.2 Hospital Pharmacy: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 10.1.2 Retail Pharmacy
- 10.1.2.1 Overview
- 10.1.2.2 Retail Pharmacy: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 10.1.3 Online Channel
- 10.1.3.1 Overview
- 10.1.3.2 Online Channel: Prefilled Syringe Market -Revenue, 2021-2034 (US$ Million)
- 10.1.1 Hospital Pharmacy
11. Prefilled Syringe Market - Geographical Analysis
- 11.1 North America
- 11.1.1 North America Prefilled Syringe Market Overview
- 11.1.2 North America: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.1.3 North America: Prefilled Syringe Market- By Segmentation
- 11.1.3.1 Type
- 11.1.3.2 Material
- 11.1.3.3 Design
- 11.1.3.4 Application
- 11.1.3.5 Distribution Channel
- 11.1.4 North America: Prefilled Syringe Market Breakdown by Countries
- 11.1.4.1 United States Market
- 11.1.4.1.1 United States: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.1.4.1.2 United States: Prefilled Syringe Market- By Segmentation
- 11.1.4.1.2.1 Type
- 11.1.4.1.2.2 Material
- 11.1.4.1.2.3 Design
- 11.1.4.1.2.4 Application
- 11.1.4.1.2.5 Distribution Channel
- 11.1.4.2 Canada Market
- 11.1.4.2.1 Canada: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.1.4.2.2 Canada: Prefilled Syringe Market- By Segmentation
- 11.1.4.2.2.1 Type
- 11.1.4.2.2.2 Material
- 11.1.4.2.2.3 Design
- 11.1.4.2.2.4 Application
- 11.1.4.2.2.5 Distribution Channel
- 11.1.4.3 Mexico Market
- 11.1.4.3.1 Mexico: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.1.4.3.2 Mexico: Prefilled Syringe Market- By Segmentation
- 11.1.4.3.2.1 Type
- 11.1.4.3.2.2 Material
- 11.1.4.3.2.3 Design
- 11.1.4.3.2.4 Application
- 11.1.4.3.2.5 Distribution Channel
- 11.1.4.1 United States Market
- 11.2 Europe
- 11.2.1 Europe Prefilled Syringe Market Overview
- 11.2.2 Europe: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.3 Europe: Prefilled Syringe Market- By Segmentation
- 11.2.3.1 Type
- 11.2.3.2 Material
- 11.2.3.3 Design
- 11.2.3.4 Application
- 11.2.3.5 Distribution Channel
- 11.2.4 Europe: Prefilled Syringe Market Breakdown by Countries
- 11.2.4.1 Germany Market
- 11.2.4.1.1 Germany: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.4.1.2 Germany: Prefilled Syringe Market- By Segmentation
- 11.2.4.1.2.1 Type
- 11.2.4.1.2.2 Material
- 11.2.4.1.2.3 Design
- 11.2.4.1.2.4 Application
- 11.2.4.1.2.5 Distribution Channel
- 11.2.4.2 United Kingdom Market
- 11.2.4.2.1 United Kingdom: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.4.2.2 United Kingdom: Prefilled Syringe Market- By Segmentation
- 11.2.4.2.2.1 Type
- 11.2.4.2.2.2 Material
- 11.2.4.2.2.3 Design
- 11.2.4.2.2.4 Application
- 11.2.4.2.2.5 Distribution Channel
- 11.2.4.3 France Market
- 11.2.4.3.1 France: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.4.3.2 France: Prefilled Syringe Market- By Segmentation
- 11.2.4.3.2.1 Type
- 11.2.4.3.2.2 Material
- 11.2.4.3.2.3 Design
- 11.2.4.3.2.4 Application
- 11.2.4.3.2.5 Distribution Channel
- 11.2.4.4 Italy Market
- 11.2.4.4.1 Italy: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.4.4.2 Italy: Prefilled Syringe Market- By Segmentation
- 11.2.4.4.2.1 Type
- 11.2.4.4.2.2 Material
- 11.2.4.4.2.3 Design
- 11.2.4.4.2.4 Application
- 11.2.4.4.2.5 Distribution Channel
- 11.2.4.5 Spain Market
- 11.2.4.5.1 Spain: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.4.5.2 Spain: Prefilled Syringe Market- By Segmentation
- 11.2.4.5.2.1 Type
- 11.2.4.5.2.2 Material
- 11.2.4.5.2.3 Design
- 11.2.4.5.2.4 Application
- 11.2.4.5.2.5 Distribution Channel
- 11.2.4.6 Rest of Europe Market
- 11.2.4.6.1 Rest of Europe: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.2.4.6.2 Rest of Europe: Prefilled Syringe Market- By Segmentation
- 11.2.4.6.2.1 Type
- 11.2.4.6.2.2 Material
- 11.2.4.6.2.3 Design
- 11.2.4.6.2.4 Application
- 11.2.4.6.2.5 Distribution Channel
- 11.2.4.1 Germany Market
- 11.3 Asia Pacific
- 11.3.1 Asia Pacific Prefilled Syringe Market Overview
- 11.3.2 Asia Pacific: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.3 Asia Pacific: Prefilled Syringe Market- By Segmentation
- 11.3.3.1 Type
- 11.3.3.2 Material
- 11.3.3.3 Design
- 11.3.3.4 Application
- 11.3.3.5 Distribution Channel
- 11.3.4 Asia Pacific: Prefilled Syringe Market Breakdown by Countries
- 11.3.4.1 China Market
- 11.3.4.1.1 China: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.4.1.2 China: Prefilled Syringe Market- By Segmentation
- 11.3.4.1.2.1 Type
- 11.3.4.1.2.2 Material
- 11.3.4.1.2.3 Design
- 11.3.4.1.2.4 Application
- 11.3.4.1.2.5 Distribution Channel
- 11.3.4.2 Japan Market
- 11.3.4.2.1 Japan: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.4.2.2 Japan: Prefilled Syringe Market- By Segmentation
- 11.3.4.2.2.1 Type
- 11.3.4.2.2.2 Material
- 11.3.4.2.2.3 Design
- 11.3.4.2.2.4 Application
- 11.3.4.2.2.5 Distribution Channel
- 11.3.4.3 India Market
- 11.3.4.3.1 India: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.4.3.2 India: Prefilled Syringe Market- By Segmentation
- 11.3.4.3.2.1 Type
- 11.3.4.3.2.2 Material
- 11.3.4.3.2.3 Design
- 11.3.4.3.2.4 Application
- 11.3.4.3.2.5 Distribution Channel
- 11.3.4.4 Australia Market
- 11.3.4.4.1 Australia: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.4.4.2 Australia: Prefilled Syringe Market- By Segmentation
- 11.3.4.4.2.1 Type
- 11.3.4.4.2.2 Material
- 11.3.4.4.2.3 Design
- 11.3.4.4.2.4 Application
- 11.3.4.4.2.5 Distribution Channel
- 11.3.4.5 South Korea Market
- 11.3.4.5.1 South Korea: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.4.5.2 South Korea: Prefilled Syringe Market- By Segmentation
- 11.3.4.5.2.1 Type
- 11.3.4.5.2.2 Material
- 11.3.4.5.2.3 Design
- 11.3.4.5.2.4 Application
- 11.3.4.5.2.5 Distribution Channel
- 11.3.4.6 Rest of APAC Market
- 11.3.4.6.1 Rest of APAC: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.3.4.6.2 Rest of APAC: Prefilled Syringe Market- By Segmentation
- 11.3.4.6.2.1 Type
- 11.3.4.6.2.2 Material
- 11.3.4.6.2.3 Design
- 11.3.4.6.2.4 Application
- 11.3.4.6.2.5 Distribution Channel
- 11.3.4.1 China Market
- 11.4 Middle East and Africa
- 11.4.1 Middle East and Africa Prefilled Syringe Market Overview
- 11.4.2 Middle East and Africa: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.4.3 Middle East and Africa: Prefilled Syringe Market- By Segmentation
- 11.4.3.1 Type
- 11.4.3.2 Material
- 11.4.3.3 Design
- 11.4.3.4 Application
- 11.4.3.5 Distribution Channel
- 11.4.4 Middle East and Africa: Prefilled Syringe Market Breakdown by Countries
- 11.4.4.1 Saudi Arabia Market
- 11.4.4.1.1 Saudi Arabia: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.4.4.1.2 Saudi Arabia: Prefilled Syringe Market- By Segmentation
- 11.4.4.1.2.1 Type
- 11.4.4.1.2.2 Material
- 11.4.4.1.2.3 Design
- 11.4.4.1.2.4 Application
- 11.4.4.1.2.5 Distribution Channel
- 11.4.4.2 South Africa Market
- 11.4.4.2.1 South Africa: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.4.4.2.2 South Africa: Prefilled Syringe Market- By Segmentation
- 11.4.4.2.2.1 Type
- 11.4.4.2.2.2 Material
- 11.4.4.2.2.3 Design
- 11.4.4.2.2.4 Application
- 11.4.4.2.2.5 Distribution Channel
- 11.4.4.3 United Arab Emirates Market
- 11.4.4.3.1 United Arab Emirates: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.4.4.3.2 United Arab Emirates: Prefilled Syringe Market- By Segmentation
- 11.4.4.3.2.1 Type
- 11.4.4.3.2.2 Material
- 11.4.4.3.2.3 Design
- 11.4.4.3.2.4 Application
- 11.4.4.3.2.5 Distribution Channel
- 11.4.4.4 Rest of Middle East and Africa Market
- 11.4.4.4.1 Rest of Middle East and Africa: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.4.4.4.2 Rest of Middle East and Africa: Prefilled Syringe Market- By Segmentation
- 11.4.4.4.2.1 Type
- 11.4.4.4.2.2 Material
- 11.4.4.4.2.3 Design
- 11.4.4.4.2.4 Application
- 11.4.4.4.2.5 Distribution Channel
- 11.4.4.1 Saudi Arabia Market
- 11.5 South and Central America
- 11.5.1 South and Central America Prefilled Syringe Market Overview
- 11.5.2 South and Central America: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.5.3 South and Central America: Prefilled Syringe Market- By Segmentation
- 11.5.3.1 Type
- 11.5.3.2 Material
- 11.5.3.3 Design
- 11.5.3.4 Application
- 11.5.3.5 Distribution Channel
- 11.5.4 South and Central America: Prefilled Syringe Market Breakdown by Countries
- 11.5.4.1 Brazil Market
- 11.5.4.1.1 Brazil: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.5.4.1.2 Brazil: Prefilled Syringe Market- By Segmentation
- 11.5.4.1.2.1 Type
- 11.5.4.1.2.2 Material
- 11.5.4.1.2.3 Design
- 11.5.4.1.2.4 Application
- 11.5.4.1.2.5 Distribution Channel
- 11.5.4.2 Argentina Market
- 11.5.4.2.1 Argentina: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.5.4.2.2 Argentina: Prefilled Syringe Market- By Segmentation
- 11.5.4.2.2.1 Type
- 11.5.4.2.2.2 Material
- 11.5.4.2.2.3 Design
- 11.5.4.2.2.4 Application
- 11.5.4.2.2.5 Distribution Channel
- 11.5.4.3 Rest of South and Central America Market
- 11.5.4.3.1 Rest of South and Central America: Prefilled Syringe Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 11.5.4.3.2 Rest of South and Central America: Prefilled Syringe Market- By Segmentation
- 11.5.4.3.2.1 Type
- 11.5.4.3.2.2 Material
- 11.5.4.3.2.3 Design
- 11.5.4.3.2.4 Application
- 11.5.4.3.2.5 Distribution Channel
- 11.5.4.1 Brazil Market
12. Prefilled Syringe Market Industry Landscape
13. Prefilled Syringe Market - Key Company Profiles
- 13.1 B Braun SE
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Delta Med SPA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Shandong Weigao Group Medical Polymer Co Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Gerresheimer AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Schott AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Nipro Corp
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Becton Dickinson and Co
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 Baxter International Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 Terumo Corp
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 Ypsomed Holding AG
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
- 14.1 Glossary
- 14.2 Research Methodology and Approach
- 14.2.1 Secondary Research
- 14.2.2 Primary Research
- 14.2.3 Market Estimation Approach
- 14.2.3.1 Supply Side Analysis
- 14.2.3.2 Demand Side Analysis
- 14.2.4 Research Assumptions and Limitations
- 14.2.5 Currency Conversion
- 14.3 About The Insight Partners
- 14.4 Market Intelligence Cloud
